Research Paper Volume 15, Issue 24 pp 14845—14863
A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer
Figure 5. (A) The correlations between the KIFC1 expressions and MHC molecule in pan-cancer. (B) The correlations between the KIFC1 expressions and chemokines in pan-cancer. (C) The correlations between the KIFC1 expressions and immunostimulators in pan-cancer. (D) The correlations between the KIFC1 expressions and immunoinhibitors in pan-cancer. Red represents a positive correlation, and blue represents a negative correlation. (E) Association between KIFC1 expression and TMB. (F) Association between KIFC1 expression and MSI. (G) Kaplan-Meier curves for low- and high-KIFC1 patient groups in IMvigor210 cohort. (H) The differential expression of KIFC1 in the CR/PR group and SD/PD group. (I) The fraction of urological tumors patients with response to anti-PD-1 therapy in low- and high-KIFC1 subgroups of IMvigor210 cohort.